DiaMedica Therapeutics Inc
DMAC
$8.04+4.96%
End of day · as of Oct 15, 2026, 8:00 PM ET
Mkt cap
$157.38M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-0.38
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
1.20
Div yield
N/A
Sector
Healthcare
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Use this DMAC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DMAC income, balance, and cash tables.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company in the Healthcare sector.
Latest cached DiaMedica Therapeutics Inc (DMAC) net income for FY2025 was -$32.8M. Statements: https://lician.com/financials/dmac
DiaMedica Therapeutics Inc (DMAC) market capitalization is $157.4M on the latest cached snapshot.
DiaMedica Therapeutics Inc (DMAC) cached previous close $7.66; day range $7.82 – $8.06; volume 303,584. Session quote: https://lician.com/quote/dmac
DiaMedica Therapeutics Inc (DMAC) latest cached earnings event is "DMAC earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DMAC filing is 8-K · Aug 10, 2026. Filings: https://lician.com/sec/dmac